vs
Enovis CORP（ENOV）与MSA Safety Inc（MSA）财务数据对比。点击上方公司名可切换其他公司
Enovis CORP的季度营收约是MSA Safety Inc的1.1倍（$548.9M vs $510.9M）。MSA Safety Inc净利率更高（17.0% vs -104.1%，领先121.1%）。MSA Safety Inc同比增速更快（2.2% vs -2.2%）。MSA Safety Inc自由现金流更多（$106.0M vs $29.1M）。过去两年MSA Safety Inc的营收复合增速更高（11.2% vs 9.8%）
Enovis是一家专注于骨科领域的医疗科技企业，其前身是1995年由米切尔·雷尔斯和史蒂文·雷尔斯兄弟创立的科尔法克斯公司。公司总部位于特拉华州威尔明顿，目前在全球12个地点开展业务，拥有超过5000名员工，于纽约证券交易所上市，股票代码为ENOV。
MSA安全是美国专业安全设备生产供应商，面向建筑、军事、消防、化工、油气等存在高危作业场景的多个行业提供安全防护产品及解决方案，总部位于美国匹兹堡近郊的克兰伯里。
ENOV vs MSA — 直观对比
营收规模更大
ENOV
是对方的1.1倍
$510.9M
营收增速更快
MSA
高出4.4%
-2.2%
净利率更高
MSA
高出121.1%
-104.1%
自由现金流更多
MSA
多$76.9M
$29.1M
两年增速更快
MSA
近两年复合增速
9.8%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $548.9M | $510.9M |
| 净利润 | $-571.1M | $86.9M |
| 毛利率 | 59.9% | 46.9% |
| 营业利润率 | -101.7% | 22.3% |
| 净利率 | -104.1% | 17.0% |
| 营收同比 | -2.2% | 2.2% |
| 净利润同比 | 18.8% | -1.2% |
| 每股收益（稀释后） | $-9.99 | $2.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ENOVMSA
| Q4 25 | $548.9M | $510.9M | ||
| Q3 25 | $564.5M | $468.4M | ||
| Q2 25 | $558.8M | $474.1M | ||
| Q1 25 | — | $421.3M | ||
| Q4 24 | $561.0M | $499.7M | ||
| Q3 24 | $505.2M | $432.7M | ||
| Q2 24 | $525.2M | $462.5M | ||
| Q1 24 | $516.3M | $413.3M |
净利润ENOVMSA
| Q4 25 | $-571.1M | $86.9M | ||
| Q3 25 | $-36.7M | $69.6M | ||
| Q2 25 | $-56.0M | $62.8M | ||
| Q1 25 | — | $59.6M | ||
| Q4 24 | $-703.2M | $87.9M | ||
| Q3 24 | $-31.5M | $66.6M | ||
| Q2 24 | $-18.6M | $72.2M | ||
| Q1 24 | $-72.0M | $58.1M |
毛利率ENOVMSA
| Q4 25 | 59.9% | 46.9% | ||
| Q3 25 | 59.3% | 46.5% | ||
| Q2 25 | 59.5% | 46.6% | ||
| Q1 25 | — | 45.9% | ||
| Q4 24 | 54.8% | 46.9% | ||
| Q3 24 | 56.7% | 47.9% | ||
| Q2 24 | 55.0% | 48.2% | ||
| Q1 24 | 57.7% | 47.3% |
营业利润率ENOVMSA
| Q4 25 | -101.7% | 22.3% | ||
| Q3 25 | -3.0% | 20.1% | ||
| Q2 25 | -8.4% | 18.1% | ||
| Q1 25 | — | 18.5% | ||
| Q4 24 | -118.5% | 23.5% | ||
| Q3 24 | -6.3% | 21.1% | ||
| Q2 24 | -8.4% | 21.6% | ||
| Q1 24 | -6.8% | 19.4% |
净利率ENOVMSA
| Q4 25 | -104.1% | 17.0% | ||
| Q3 25 | -6.5% | 14.9% | ||
| Q2 25 | -10.0% | 13.2% | ||
| Q1 25 | — | 14.1% | ||
| Q4 24 | -125.4% | 17.6% | ||
| Q3 24 | -6.2% | 15.4% | ||
| Q2 24 | -3.5% | 15.6% | ||
| Q1 24 | -13.9% | 14.1% |
每股收益（稀释后）ENOVMSA
| Q4 25 | $-9.99 | $2.22 | ||
| Q3 25 | $-0.64 | $1.77 | ||
| Q2 25 | $-0.98 | $1.59 | ||
| Q1 25 | — | $1.51 | ||
| Q4 24 | $-12.69 | $2.22 | ||
| Q3 24 | $-0.58 | $1.69 | ||
| Q2 24 | $-0.34 | $1.83 | ||
| Q1 24 | $-1.32 | $1.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $33.6M | $165.1M |
| 总债务越低越好 | $1.4B | $580.9M |
| 股东权益账面价值 | $2.0B | $1.4B |
| 总资产 | $4.4B | $2.6B |
| 负债/权益比越低杠杆越低 | 0.67× | 0.42× |
8季度趋势，按日历期对齐
现金及短期投资ENOVMSA
| Q4 25 | $33.6M | $165.1M | ||
| Q3 25 | $44.1M | $170.0M | ||
| Q2 25 | $38.5M | $147.0M | ||
| Q1 25 | — | $170.6M | ||
| Q4 24 | $48.2M | $164.6M | ||
| Q3 24 | $35.4M | $154.4M | ||
| Q2 24 | $35.0M | $146.8M | ||
| Q1 24 | $66.3M | $148.3M |
总债务ENOVMSA
| Q4 25 | $1.4B | $580.9M | ||
| Q3 25 | $1.4B | $628.6M | ||
| Q2 25 | $1.4B | $679.3M | ||
| Q1 25 | — | $502.1M | ||
| Q4 24 | $1.3B | $508.0M | ||
| Q3 24 | $1.3B | $554.7M | ||
| Q2 24 | $1.3B | $588.2M | ||
| Q1 24 | $1.3B | $596.2M |
股东权益ENOVMSA
| Q4 25 | $2.0B | $1.4B | ||
| Q3 25 | $2.6B | $1.3B | ||
| Q2 25 | $2.6B | $1.3B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | $2.6B | $1.1B | ||
| Q3 24 | $3.3B | $1.1B | ||
| Q2 24 | $3.3B | $1.0B | ||
| Q1 24 | $3.3B | $994.8M |
总资产ENOVMSA
| Q4 25 | $4.4B | $2.6B | ||
| Q3 25 | $5.0B | $2.6B | ||
| Q2 25 | $4.9B | $2.6B | ||
| Q1 25 | — | $2.2B | ||
| Q4 24 | $4.7B | $2.2B | ||
| Q3 24 | $5.6B | $2.2B | ||
| Q2 24 | $5.4B | $2.2B | ||
| Q1 24 | $5.5B | $2.2B |
负债/权益比ENOVMSA
| Q4 25 | 0.67× | 0.42× | ||
| Q3 25 | 0.54× | 0.48× | ||
| Q2 25 | 0.53× | 0.54× | ||
| Q1 25 | — | 0.42× | ||
| Q4 24 | 0.52× | 0.44× | ||
| Q3 24 | 0.40× | 0.51× | ||
| Q2 24 | 0.41× | 0.57× | ||
| Q1 24 | 0.40× | 0.60× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $82.6M | $122.4M |
| 自由现金流经营现金流 - 资本支出 | $29.1M | $106.0M |
| 自由现金流率自由现金流/营收 | 5.3% | 20.8% |
| 资本支出强度资本支出/营收 | 9.7% | 3.2% |
| 现金转化率经营现金流/净利润 | — | 1.41× |
| 过去12个月自由现金流最近4个季度 | $22.8M | $295.4M |
8季度趋势，按日历期对齐
经营现金流ENOVMSA
| Q4 25 | $82.6M | $122.4M | ||
| Q3 25 | $47.8M | $112.5M | ||
| Q2 25 | $-1.6M | $67.2M | ||
| Q1 25 | — | $61.8M | ||
| Q4 24 | $88.3M | $107.9M | ||
| Q3 24 | $53.6M | $84.3M | ||
| Q2 24 | $7.8M | $53.3M | ||
| Q1 24 | $-36.2M | $50.9M |
自由现金流ENOVMSA
| Q4 25 | $29.1M | $106.0M | ||
| Q3 25 | $3.4M | $100.5M | ||
| Q2 25 | $-44.9M | $37.9M | ||
| Q1 25 | — | $51.0M | ||
| Q4 24 | $35.1M | $93.5M | ||
| Q3 24 | $2.4M | $70.1M | ||
| Q2 24 | $-31.6M | $39.0M | ||
| Q1 24 | $-73.1M | $39.7M |
自由现金流率ENOVMSA
| Q4 25 | 5.3% | 20.8% | ||
| Q3 25 | 0.6% | 21.4% | ||
| Q2 25 | -8.0% | 8.0% | ||
| Q1 25 | — | 12.1% | ||
| Q4 24 | 6.3% | 18.7% | ||
| Q3 24 | 0.5% | 16.2% | ||
| Q2 24 | -6.0% | 8.4% | ||
| Q1 24 | -14.2% | 9.6% |
资本支出强度ENOVMSA
| Q4 25 | 9.7% | 3.2% | ||
| Q3 25 | 7.9% | 2.6% | ||
| Q2 25 | 7.7% | 6.2% | ||
| Q1 25 | — | 2.6% | ||
| Q4 24 | 9.5% | 2.9% | ||
| Q3 24 | 10.1% | 3.3% | ||
| Q2 24 | 7.5% | 3.1% | ||
| Q1 24 | 7.2% | 2.7% |
现金转化率ENOVMSA
| Q4 25 | — | 1.41× | ||
| Q3 25 | — | 1.62× | ||
| Q2 25 | — | 1.07× | ||
| Q1 25 | — | 1.04× | ||
| Q4 24 | — | 1.23× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | 0.74× | ||
| Q1 24 | — | 0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ENOV
| Reconstructive Segment | $258.0M | 47% |
| Surgical | $129.0M | 23% |
| Prevention And Recovery | $92.6M | 17% |
| Other Prevention And Recovery | $71.4M | 13% |
MSA
| Americas Segment | $335.2M | 66% |
| International Segment | $175.7M | 34% |
